Analyst Says He’s Buying Merck (MRK) as ‘Market Turns Towards Quality’

Group 1 - Merck & Co., Inc. (NYSE:MRK) is identified as a trending stock this week, with notable interest from investors [1] - Joseph Terranova, a Senior Managing Director at Virtus Investment Partners, has recently purchased shares of Merck, indicating a shift in market focus towards quality stocks, particularly in the healthcare sector [2] - Impax US Sustainable Economy Fund highlighted Merck's high Corporate Resilience score and its contributions to a sustainable healthcare system, although noted that the stock faced weakness in Q2 due to concerns over its drug pipeline and competition from generics [2] Group 2 - The overall sentiment in the market is shifting towards quality investments, with healthcare stocks expected to benefit from this trend [2] - Despite the potential of Merck as an investment, there is a belief that certain AI stocks may offer higher returns with limited downside risk [2]